Tg Therapeutics (TGTX) Asset Utilization Ratio (2018 - 2026)

Tg Therapeutics' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.54 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 13.68% year-over-year to 0.54; the TTM figure through Mar 2026 stood at 0.54 (down 13.68% YoY), while the FY2025 annual figure was 0.75, up 3.57% from the prior year.
• Asset Utilization Ratio was 0.54 for Q1 2026 at Tg Therapeutics, down from 0.59 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.9 in Q2 2024 to a low of 0.01 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.44 across 5 years, with a median of 0.57 in 2024.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 5127.3% in 2023, then declined 25.38% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then surged by 5127.3% to 0.71 in 2023, then declined by 20.06% to 0.57 in 2024, then climbed by 4.38% to 0.59 in 2025, then retreated by 8.45% to 0.54 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.54 (Q1 2026), 0.59 (Q4 2025), and 0.62 (Q3 2025), per Business Quant data.